⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001895952

Kaplan Matthew L.

Reports to the SEC for 1 company · FORT LEE, NJ

Transactions

8

Companies

1

Filings

7

CIK

0001895952

Forms 4 and 5

Insider transactions

8 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	NVCTNuvectis Pharma, Inc.A Award	Director	AAward	+35K sh	—	—	159,760
2025-11-05	NVCTNuvectis Pharma, Inc.P Purchase	Director	PPurchase	+11K sh	$5.84	+$64.2K	124,760
2025-06-12	NVCTNuvectis Pharma, Inc.A Award	Director	AAward	+30K sh	—	—	113,760
2024-06-13	NVCTNuvectis Pharma, Inc.A Award	Director	AAward	+30K sh	—	—	83,760
2023-06-16	NVCTNuvectis Pharma, Inc.A Award	Director	AAward	+18K sh	—	—	53,760
2022-05-12	NVCTNuvectis Pharma, Inc.P Purchase	Director	PPurchase	+1,177 sh	$15.96	+$18.8K	33,937
2022-05-12	NVCTNuvectis Pharma, Inc.P Purchase	Director	PPurchase	+1,823 sh	$17.47	+$31.8K	35,760
2022-04-01	NVCTNuvectis Pharma, Inc. · Stock Options (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000

Recent filings

7

Accepted (ET)
Jun 124
Kaplan Matthew L.0001104659-26-073455
SEC(opens sec.gov)
Nov 64
Kaplan Matthew L.0001104659-25-107418
SEC(opens sec.gov)
Jun 124
Kaplan Matthew L.0001104659-25-058919
SEC(opens sec.gov)
Jun 134
Kaplan Matthew L.0001104659-24-071289
SEC(opens sec.gov)
Jun 204
Kaplan Matthew L.0001104659-23-072606
SEC(opens sec.gov)
May 164
Kaplan Matthew L.0001104659-22-060910
SEC(opens sec.gov)
Apr 54
Kaplan Matthew L.0001104659-22-042821
SEC(opens sec.gov)

Companies

1

Nuvectis Pharma, Inc.DirectorNVCT

Address

C/O NUVECTIS PHARMA, INC., 1 BRIDGE PLAZA, SUITE 275

FORT LEE, NJ, 07024